tirzepatide in ghana FDA Grants a New Indication for Obesity Management SURPASS-CVOT Published: Large Trial Confirms
Description
adults are either obese or overweight, increasing their risk for serious conditions like high blood pressure, diabetes, and sleep apnea
Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans
A class-action lawsuit challenging the decision was filed in September and remains active
And who am I to review this
